1. Kim US, Yu SY, Kwak HW. Incidence and postoperative visual outcome of Terson's syndrome. J Korean Ophthalmol Soc. 2002; 43:2451–2456.
2. Timberlake WH, Kubik CS. Follow-up report with clinical and anatomical notes on 280 patients with subarachnoid hemorrhage. Trans Am Neurol Assoc. 1952; 56:26–30. PMID:
13038783.
3. Shaw HE Jr, Landers MB, Sydnor CF. The significance of intraocular hemorrhages due to subarachnoid hemorrhage. Ann Ophthalmol. 1977; 9:1403–1405.
4. Frizzell RT, Kuhn F, Morris R, Quinn C, Fisher WS 3rd. Screening for ocular hemorrhages in patients with ruptured cerebral aneurysms: a prospective study of 99 patients. Neurosurgery. 1997; 41:529–533. PMID:
9310968.
Article
5. Swallow CE, Tsuruda JS, Digre KB, Glaser MJ, Davidson HC, Harnsberger HR. Terson syndrome: CT evaluation in 12 patients. AJNR Am J Neuroradiol. 1998; 19:743–747. PMID:
9576666.
6. Wiethölter S, Steube D, Stotz HP. Terson syndrome: a frequently missed ophthalmologic complication in subarachnoid hemorrhage. Zentralbl Neurochir. 1998; 59:166–170. PMID:
9816667.
7. Chiappa KH. Principle of evoked potentials. In : Chiappa KH, editor. Evoked potentials in clinical medicine. 3rd ed. Philadelphia: Lippincott-Raven;1977. p. 1–30.
8. Wade DT, Skilbeck CE, Hewer RL. Predicting Barthel ADL score at 6 months after an acute stroke. Arch Phys Med Rehabil. 1983; 64:24–28. PMID:
6849630.
9. Middleton K, Esselman P, Lim PC. Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage. Am J Phys Med Rehabil. 2012; 91:271–274. PMID:
22019969.
10. Shaw HE Jr, Landers MB 3rd. Vitreous hemorrhage after intracranial hemorrhage. Am J Ophthalmol. 1975; 80:207–213. PMID:
1155559.
Article